ERIS Lifesciences consolidated net profit declines 18.60% in the December 2024 quarter
Sales rise 49.36% to Rs 722.12 crore
Net profit of ERIS Lifesciences declined 18.60% to Rs 83.63 crore in the quarter ended December 2024 as against Rs 102.74 crore during the previous quarter ended December 2023. Sales rose 49.36% to Rs 722.12 crore in the quarter ended December 2024 as against Rs 483.48 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales722.12483.48 49 OPM %34.6636.30 -PBDT197.36161.59 22 PBT116.16115.87 0 NP83.63102.74 -19Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 04 2025 | 1:26 PM IST